Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-220-5 | CAS number: 3033-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-05-28 to 1993-01-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- The GLP study was conducted according to internal study methods (BRRC Project No. 91-15-18271) and in accordance with Organization for Economic Cooperation and Development Guidelines for Testing Chemicals Health Effects Test Guidelines, Office of Toxic Substances, U. S. Environmental Protection Agency (TSCA) 40 CFR Part 798.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- The study was conducted according to internal study methods (BRRC Project No. 91-15-18271) and in accordance with Organization for Economic Cooperation and Development Guidelines for Testing Chemicals Health Effects Test Guidelines, Office of Toxic Substances, U. S. Environmental Protection Agency (TSCA) 40 CFR Part 798.
- GLP compliance:
- yes
- Type of assay:
- other: mammalian erythrocyte micronucleus test (migrated information)
Test material
- Reference substance name:
- N,N,N',N'-tetramethyl-2,2'-oxybis(ethylamine)
- EC Number:
- 221-220-5
- EC Name:
- N,N,N',N'-tetramethyl-2,2'-oxybis(ethylamine)
- Cas Number:
- 3033-62-3
- Molecular formula:
- C8H20N2O
- IUPAC Name:
- {2-[2-(dimethylamino)ethoxy]ethyl}dimethylamine
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): N,N,N',N'-tetramethyl-2,2'-oxybis(ethylamine)
- Substance type: Pure actuve substance
- Physical state: Clear liquid
- Analytical purity: 96.2%
- Storage condition of test material: Stored at room temperature
- Lot/batch No.: Lot No. 84505, Sample No. 54-109
- Impurities (identity and concentrations): 0.5% DMEA, 0.08% 117 MW Amine, 1.7% 133 MW Dimethylamine, 0.06% 146 MW Amine, 0.03% 160 MW Amine, 0.9% DMAE- Dimethylaminoethyl ethanediamine (EDA), 0.15% 174 MW Amine (combined), 0.3% Other purities.
- Composition of test material, percentage of components: 96.2 Test substance, 0.5% DMEA, 0.08% 117 MW Amine, 1.7% 133 MW Dimethylamine, 0.06% 146 MW Amine, 0.03% 160 MW Amine, 0.9% DMAE- Dimethylaminoethyl ethanediamine (EDA), 0.15% 174 MW Amine (combined), 0.3% Other purities.
Test animals
- Species:
- mouse
- Strain:
- Swiss Webster
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, (Portage, MI)
- Age at study initiation: Approximately 5 weeks old
- Weight at study initiation: 23.5 to 28.8 g for males and 19.7 to 22.6 g for females
- Assigned to test groups randomly: [Yes, under following basis: Following the pretest body weight, the animals were assigned to 3 treatment groups, a vehicle control group, and a positive control group using a nonstratified randomization procedure based on body weight. At the time of group assignment, only animals with body weights within two standard deviations of the population mean for each sex were included.]
- Fasting period before study: N/A
- Housing: Group housed in shoe-box type plastic cages (30.0 X 20.0 X 12.5 cm)
- Diet (e.g. ad libitum): Pelleted, certified AGWAY PROLAB Animal Diet Rat, Mouse, Hamster 3000 (Agway Inc.) was available d libitum
- Water (e.g. ad libitum): Tap water (Municipal Authority of Westmoreland County, Greensburg, PA) was available ad libitum
- Acclimation period: Approximately 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 4 deg C
- Humidity (%): 40-70%
- Air changes (per hr): N/A
- Photoperiod (hrs dark / hrs light): 12-hour photoperiod (approximately 0500 to 1700 hours for the light phase)
IN-LIFE DATES: From: 1991-05-27 To: 1991-06-07
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Sterile, distilled, deionized water
- Justification for choice of solvent/vehicle: N/A
- Concentration of test material in vehicle: N/A
- Amount of vehicle (if gavage or dermal): 10 ml/kg
- Type and concentration of dispersant aid (if powder): N/A
- Lot/batch no. (if required): BRRC Sample Nos. 53-101A through U
- Purity: N/A - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Each test substance dosing solution was prepared by diluting the test substance in water. Concentrations were not adjusted for percent active ingredient of test substance. They were prepared on the day of treatment and were stored at room temperature prior to use. The TEM positive control dosing solution was prepared by dissolving it in ethanol then diluting it with sterile, distilled, deionized water. It was
prepared on the day of treatment and was stored at room temperature prior to use.
DIET PREPARATION
- Rate of preparation of diet (frequency): On the day of treatment
- Mixing appropriate amounts with (Type of food): N/A
- Storage temperature of food: N/A
- Justification for dose concentration: Based upon mortality data obtained in a range-finding study, the acute intraperitoneal LD50 for the combined sexes was calculated to be 181 mg/kg (no 95% confidence interval was calculated since none of the dose levels had partial survival). The doses for the definitive micronucleus assay were selected by the study director as approximately 25%, 50%, and 80% of the LD50 or 45, 90, and 145 mg/kg of the test substance. - Duration of treatment / exposure:
- 72 hours
- Frequency of treatment:
- Single dose
- Post exposure period:
- 3 days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 45 mg/kg diet
- Remarks:
- nominal concentration
- Dose / conc.:
- 90 mg/kg diet
- Remarks:
- nominal concentration
- Dose / conc.:
- 145 mg/kg diet
- Remarks:
- nominal concentration
- No. of animals per sex per dose:
- 5/sex/ treated with 45 or 90 mg/kg
8/sex/treated with 145 mg/kg
5/sex/treated with either the vehicle control (water, 10.0 ml/kg) or positive control (triethylenemelamine, 0.30 mg/kg) - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Positive control: triethylenemelamine (Lot No. 84505, BRRC Sample No. 52-793)
- Justification for choice of positive control(s): Consistently produced positive responses in prior tests; Peripheral blood was collected 30 hours
after treatment.
- Route of administration: Single intraperitoneal injection
- Doses / concentrations: 0.30 mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow, polychromatophilic erythrocytes (PCE) and normochromic erythrocytes (NCE).
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The test substance doses of approximately 25%, 50%, and 80% of the LD50, or 45, 90, and 145 mg/kg were selected by the Study Director and were based upon the results of the range-finding study that was a part of this experimental protocol.
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): Blood samples were collected approximately 30, 48 and 72 hours after dosing. Blood samples were collected from the positive control animals approximately 30 hr after dosing.
DETAILS OF SLIDE PREPARATION: Slides were coded with the randomly-assigned animal numbers and read without knowledge of the treatment group to prevent bias.
METHOD OF ANALYSIS: Blood samples of one to a few drops were collected by nicking the tail with a scalpel. One or two blood smears were made per animal per sampling time. Micronuclei in peripheral polychromatic erythrocytes were stained with Curres 8-66 Ciemsa diluted in phosphate buffer. Slides were coded with the randomly-assigned animal numbers and read without knowledge of the treatment group to prevent bias. The PCE:NCE ratio for approximately 1000 total cells will be calculated, recorded, and shown in the final report to provide an estimate of the cytotoxicity of the test agent. Excessive cytotoxicity in this test system will be defined by a PCE:NCE ratio of 0.01 or lower. Mice with an excessive reduction in the PCE:NCE ratio will be identified in the raw data and final report.
OTHER: N/A - Evaluation criteria:
- One to a few drops of blood were collected from the tail by nicking it with a scalpel. One or two blood smear slides were prepared/animal/sampling time. Micronuclei in peripheral blood polychromatophilic erythrocytes were stained with Gurr's R-66 Giemsa diluted in phosphate buffer. Slides were coded with the randomly-assigned animal number and read without knowledge of treatment group to prevent bias. Slides were identified by BRRC project number, animal number and sampling interval.
The PCE:NCE ratio for a total of 1000 cells for each animal was calculated to provide an estimate of test substance cytotoxicity. A minimum of 1000 PCE for each animal were scored for the presence of micronuclei unless the cytotoxicity of the test substance prevented this. - Statistics:
- Data were statistically evaluated using the Mann-Whitney U test. All statistical analyses were performed using BMDP Statistical Software. For all statistical tests, the probability value of < 0.05 (two-tailed) was used as the critical level of significance. Various models of calculators, computers, and computer programs may have been used to analyze data for this study. Since various models round or truncate numbers differently, values in some tables may differ slightly from those in other tables or from independently calculated data. The integrity of the study and interpretation of the data were unaffected by these differences.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 32, 64, 128,256 and 512 mg/kg
- Solubility: N/A
- Clinical signs of toxicity in test animals: The aniamls were observed for signs of toxic and/or pharmacological effects for 72 hr after dosing. Blood was taken from the tail vein at 48 hr and 72 hr after dosing from the 128 mg/kg and water control animals, and was used for determining the ratio of polychromatophilic erythrocytes (PCE) to normochromic erythrocytes (NCE). Body weights were measured before dosing and before sacrifice on the fourth day after dosing (approximately 72 hr postdosing), 5 of 5 males and females were found dead in the 256 and 512 mg/kg dose groups after 72 hours. By the end of the 72 hr observation period, the body weights of the 128 mg/kg males were statistically significantly reduced; whilst those of the females of this dosage group were also reduced, this was not statistically significant. By 72 hr, body weight gains for both males and females were reduced.
- Evidence of cytotoxicity in tissue analyzed: 48 hr sample for 0 mg/kg= 27.6 +/- 2.1 PCE/NCE (male) and 38.0 +/- 8.0 PCE/NCE (female); 72 hr sample for 0 mg/kg= 27.0 +/- 2.6 PCE/NC (male) and 33.0 +/- 6.2 PCE/NCE; 48 hr for 128 mg/kg= 28.6 +/- 5.0 (male) and 35.8 +/- 9.6 (female); 72 hr for 128 mg/kg= 26.4 +/- 5.6 (male) and 29.4 +/- 8.8 (female). The findings showed no evidence for bone marrow toxicity from the test substance given ip at a dosage of 128 mg/kg.
- Rationale for exposure: N/A
- Harvest times: 48 and 72 hours
- High dose with and without activation: N/A
- Other: The control group received ip distilled water (10 ml/kg).
RESULTS OF DEFINITIVE STUDY
- Types of structural aberrations for significant dose levels (for Cytogenetic or SCE assay): N/A
- Induction of micronuclei (for Micronucleus assay): Blood samples of one to a few drops were collected by nicking the tail with a scalpel. One or two blood smears were made per animal per sampling time. Micronuclei in peripheral polychromatic erythrocytes were stained with Curres 8-66 Ciemsa diluted in phosphate buffer. Slides were coded with the randomly-assigned animal numbers and read without knowledge of the treatment group to prevent bias. The PCE:NCE ratio for approximately 1000 total cells will be calculated, recorded, and shown in the final report to provide an estimate of the cytotoxicity of the test agent. Excessive cytotoxicity in this test system will be defined by a PCE:NCE ratio of 0.01 or lower. Mice with an excessive reduction in the PCE:NCE ratio will be identified in the raw data and final report.
- Ratio of PCE/NCE (for Micronucleus assay): The ratio of PCE/NCE was determined to assess any bone marrow cytotoxicity, and the number of micronucleated erythrocytes was counted and expressed as the proportion of polychromatophilic erythrocytes with micronuclei. There were no significant decreases in PCE/NCE ratios at any dosage, indicating an absence of bone marrow cytotoxicity. There were no significant changes in the incidence of micronucleated polychromatophils with either sex at any dosage, when compared with the water-alone controls. The positive control, TEM, produced highly statistically significant increases in micronucleated polychromatophils with evidence of cytotoxicity.
- Appropriateness of dose levels and route: Yes
- Statistical evaluation: See Statistics section above
Any other information on results incl. tables
The above dosage-mortality data allowed the calculation of a 72 hr-ip LD50 of 181 mg kg- for both male and female Swiss-Webster mice. By the end of the 72 hr observation period, the body weights of the 128 mg kg males were statistically significantly reduced; whilst those of the females of this dosage group were also reduced, this was not statistically significant. By 72 hr, body weight gains for both males and females were reduced.
Results of the mouse peripheral blood micronucleus test with the test substance given by intraperitoneal injection
Group |
Dosage |
Sex |
PCE/NCE (% Controls)a |
Micronuclei (% PCE with MN) |
||||
30 hr |
48 hr |
72 hr |
30 hr |
48 hr |
72 hr |
|||
Waterb |
10 ml/kg |
Male |
|
|
|
0.40 |
0.30 |
0.44 |
Female |
- |
- |
|
0.24 |
0.12 |
0.24 |
||
Test substance |
45 ml/kg |
Male |
113.0 |
126.4 |
101.5 |
0.46 |
0.26 |
0.34 |
Female |
106.4 |
107.8 |
104.2 |
0.28 |
0.3 |
0.16 |
||
90 ml/kg |
Male |
111.6 |
114.4 |
112.5 |
0.34 |
0.20 |
0.34 |
|
Female |
88.5 |
97.4 |
109.7 |
0.28 |
0.02 |
0.36 |
||
145 ml/kg |
Male |
103.4 |
116.8 |
105.9 |
0.48 |
0.26 |
0.42 |
|
Female |
91.1 |
94.2 |
113.2 |
0.20 |
0.16 |
0.24 |
||
Positive controlc |
0.3 ml/kg |
Male |
46.6 |
|
- |
2.90 |
|
|
Female |
39.5 |
|
|
2.10 |
|
|
ARatio of polychromatophilic erythrocytes to normochromic erythrocytes as % of control
(water) values.
BControl group.
CTEM = triethylenemelamine positive control (30 hr sample only).
Applicant's summary and conclusion
- Conclusions:
- The test substance did not produce significant, treatment-related increases in the incidence of micronucleated polychromatophilic erythrocytes among male or female Swiss-Webster mice assessed at concentrations of 45, 90, or 145 mg/kg did not produce significant, treatment-related increases in the incidence of micronucleated polychromatophilic erythrocytes among male or female Swiss-Webster mice assessed at 30, 48, or 72 hours after treatment with a single dose by intraperitoneal injection. Therefore, the test substance was not considered to be an inducer of micronuclei in male or female Swiss-Webster mice under the conditions of this in vivo assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.